CareCloud, Inc. (CCLD) vs Cognition Therapeutics, Inc. (CGTX)

A side-by-side comparison of CareCloud, Inc. and Cognition Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
CareCloud, Inc. logo
CCLD
CareCloud, Inc.
$88M
$2.07HealthcareDelayed quote: Oct 6, 2026, 10:07 AM EDT
Cognition Therapeutics, Inc. logo
CGTX
Cognition Therapeutics, Inc.
$85M
$0.95HealthcareDelayed quote: Oct 6, 2026, 10:07 AM EDT

Total return — CCLD vs CGTX

growth of $100 · dividends reinvested · last 5y
CCLD -74.2% (-23.7%/yr)CGTX -92.7% (-40.7%/yr)CCLD compounded faster over this window
020406080100Start $10020222023202420252026$26$7
CCLD CGTX

CCLD vs CGTX: by the numbers

  • •CCLD is the larger company ($88M vs $85M market cap).
  • •CCLD is profitable (6.21% net margin) while CGTX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricCCLDCGTX
P/E ratio29.58N/A
Forward P/E7.51N/A
P/S ratio0.68N/A
P/B ratio5.042.57
EV / EBITDA4.67N/A
FCF yield24.70%N/A

Profitability

MetricCCLDCGTX
Gross margin46.51%0.00%
Operating margin7.31%0.00%
Net margin6.21%0.00%
ROE45.93%-50.80%
ROIC12.79%-109.43%

Growth (annualized)

MetricCCLDCGTX
Revenue CAGR (5Y)0.18%N/A
Total return CAGR (5Y)-23.18%N/A

Frequently asked

Is CCLD or CGTX more profitable?
CCLD runs the higher net margin — CCLD at 6.21% versus CGTX at 0.00%.

Go deeper

Full CCLD analysisFull CGTX analysisInteractive comparison tool

Dig into the metrics

CareCloud P/E ratioCareCloud ROECognition Therapeutics ROECareCloud operating marginCognition Therapeutics operating marginCareCloud revenue growthCognition Therapeutics revenue growthCareCloud free cash flowCognition Therapeutics free cash flow

CareCloud & Cognition Therapeutics appear in these rankings

Highest ROE StocksHighest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.